outcome of using radiofrequency alone versus radiofrequency preceded by percutaneous ethanol injection for the treatment of hepatocellular carcinoma

Radiofrequency ablation [RFA] and percutaneous ethanol injection [PEI] therapy are currently used for the treatment of hepatocellular carcinoma [HCC]. The objective of this study was to compare the efficacy and safety of combined PEI-RFA versus RFA alone for ablation of HCC. Twenty seven patients with liver cirrhosis and HCC which was 5